News-Medical.Net on MSN
Ripple & Bausch’s licensing agreement: What it means in ocular delivery
Ripple Therapeutics, a clinical-stage company developing polymer-free sustained release drug delivery systems, has entered ...
Leon Bellan, associate professor of mechanical and biomedical engineering at Vanderbilt, and his team have developed a novel ...
African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...
Artificial lipid bilayer vesicle liposomes, also called proteoliposomes, are specialized systems capable of incorporating various molecules, such as chemicals and drugs. Their unique properties make ...
Using nanotechnology, scientists from UCLA and Northwestern University have developed a localized and controlled drug delivery method that is invisible to the immune system, a discovery that could ...
Dublin, Aug. 23, 2017 (GLOBE NEWSWIRE) -- The "Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022" report has been added to Research and Markets' offering. Global Controlled Drug ...
Controlled drug delivery systems represent a dynamic field that integrates materials science, engineering and pharmacology to achieve precise therapeutic outcomes. These systems are designed to ...
Kanazawa University, report the successful creation of artificial synaptic vesicles that can be remotely controlled by ...
For many people, injection needles can be scary – and the larger ones for specialized longer-term medications are far more intimidating. Many long-lasting drugs typically need to be delivered through ...
A new method using a combination of strong and weak electric fields to change nanoparticle speed and direction could improve ...
On December 4, AEI’s Brian J. Miller hosted Rep. Larry Buchson (R-IN), Georges C. Benjamin of the American Public Health Association, Brian Fumio Yagi of Johns Hopkins University, and Boris D.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results